Plain-English translation of NCT04494776 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers are not testing a new medication, but rather gathering real-world information from kidney transplant recipients who have been diagnosed with COVID-19. The study aims to understand how COVID-19 affects transplant patients differently, since their immune systems are weakened by the medications they take to prevent transplant rejection. By collecting data from 500 patients across Brazil, researchers hope to learn more about which patients are at highest risk for serious complications.
Kidney transplant recipients take medications that suppress their immune system to protect their new organ, which may make them more vulnerable to severe COVID-19. Right now, doctors don't have enough information about how COVID-19 progresses in this population, so this study aims to fill that gap and help future patients receive better care.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your medical records and collect information about your COVID-19 infection, symptoms, any hospitalizations or intensive care needs, and your health status for up to 3 months after your infection. You will not be given any experimental medication—instead, you'll simply allow the research team to gather data about your actual medical care and outcomes. Participation can happen whether you're recovering at home or being treated in a hospital.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Brazil